SCHEMBL455723

SCHEMBL455723

CCNOCCONCC

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3781612 0.87
SCHEMBL309238 0.86
SCHEMBL6567270 0.85
SCHEMBL6566822 0.83 ALDH1A1 (0.38)
SCHEMBL6565719 0.83 ALDH1A1 (0.38)
SCHEMBL309203 0.81
SCHEMBL503563 0.81
SCHEMBL243710 0.81
SCHEMBL4365811 0.81
SCHEMBL8956607 0.81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12310268-B2 Neuromorphic memristor device based on vertically-oriented halide perovskite nanostructure and method of manufacturing the same Seoul National Unviersity R&DBFoundation (KR) 2025-05-20 US claimed
CN-115417987-B Preparation method and application of vegetable oil-based non-isocyanate waterborne polyurethane 湖北好口福食品有限公司 2024-06-25 CN claimed
EP-4359475-A1 USE OF ORGANIC CATIONIC COMPOUNDS TO ACCELERATE NUCLEIC ACID HYBRIDIZATION, SYNTHESIS, AND AMPLIFICATION Enzo Biochem, Inc. (US) 2024-05-01 EP claimed
US-20230172082-A1 NEUROMORPHIC MEMRISTOR DEVICE BASED ON VERTICALLY-ORIENTED HALIDE PEROVSKITE NANOSTRUCTURE AND METHOD OF MANUFACTURING THE SAME SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2023-06-01 US claimed
WO-2022272207-A1 USE OF ORGANIC CATIONIC COMPOUNDS TO ACCELERATE NUCLEIC ACID HYBRIDIZATION, SYNTHESIS, AND AMPLIFICATION ENZO BIOCHEM, INC. (US) 2022-12-29 WO claimed
US-20220290005-A1 COATINGS WITH TUNABLE AMINE DENSITY Cowper Sciences Inc. 2022-09-15 US claimed
CN-111362422-B Magnetic complex-cyanide lyase composite nanoparticle, preparation method and application thereof, and method for treating electroplating wastewater by using magnetic complex-cyanide lyase composite nanoparticle 山东普尼奥水处理科技有限公司 2022-05-10 CN claimed
CN-111362422-A Magnetic complex-cyanide lyase composite nano-particles, preparation method and application thereof, and method for treating electroplating wastewater by using magnetic complex-cyanide lyase composite nano-particles 杭州传一科技有限公司 2020-07-03 CN claimed
EP-3538591-A1 COATINGS WITH TUNABLE AMINE DENSITY Healthtell Inc. (US) 2019-09-18 EP claimed
WO-2018089556-A1 COATINGS WITH TUNABLE AMINE DENSITY HEALTHTELL INC. (US) 2018-05-17 WO claimed
EP-4734929-A1 SYSTEM AND METHODS FOR MODIFYING SURFACE PROPERTIES OF KERATIN-CONTAINING SURFACES Edulis Labs Inc. (US) 2026-05-06 EP disclosed
US-12595356-B2 Composite particle and use thereof in optical filtration COLOURSMITH LABS INC. (CA) 2026-04-07 US disclosed
EP-4230775-B1 TIN ALLOY PLATING SOLUTION MITSUBISHI MATERIALS CORP (JP) 2026-03-04 EP disclosed
EP-3611247-B2 FABRIC TREATMENT COMPOSITIONS COMPRISING BENEFIT AGENT CAPSULES PROCTER & GAMBLE (US) 2026-01-07 EP disclosed
US-12519071-B2 Structure containing Sn layer or Sn alloy layer ISHIHARA CHEMICAL CO., LTD. (JP) 2026-01-06 US disclosed
EP-2056106-A1 SUGAR CHAIN-CAPTURING SUBSTANCE AND USE THEREOF Sumitomo Bakelite Company, Ltd. (JP) 2009-05-06 EP disclosed
US-20080097061-A1 Oxylamino Group-Containing Compound and Polymer NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) 2008-04-24 US disclosed
US-20020151089-A1 Separating components of biological samples MIRAIBIO, INC. 2002-10-17 US disclosed
EP-0910351-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. Searle & Co. (US) 1999-04-28 EP disclosed
WO-1997049387-A1 PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS G.D. SEARLE AND CO. (US) 1997-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595356-B2 Composite particle and use thereof in optical filtration CHLSN, PPOX, AHR TP53 1696/4885
US-20220290005-A1 COATINGS WITH TUNABLE AMINE DENSITY CHRM1, C5, CHRM2 TP53 1648/4885
US-20080097061-A1 Oxylamino Group-Containing Compound and Polymer MAOB, OPRM1, OXER1 TP53 4601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.